Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity lowers target price on Synthomer

(Sharecast News) - Analysts at Canaccord Genuity lowered their target price on chemicals business Synthomer from 350.0p to 300.0p on Wednesday as it effectively pushed out its expectations for the group's recovery by 12 months. Canaccord Genuity said the September 2023 recapitalisation of Synthomer had left the group "well-placed to survive the current extended downturn". However, the outlook for the current year was still for limited progress.

"We are moving numbers to the right, effectively pushing the recovery out by a year; we now expect nearly all of the improvement in 2024E to be self-help, with better figures coming next year," said Canaccord Genuity. "The impact on our valuation is more modest, given that we now look well set for a sustained recovery in the chemicals industry, and we are effectively pushing out our valuation by one year".

The Canadian bank noted that Given Synthomer's equity gearing - at the current share price, the equity value sits at around 28% of the enterprise value - even a "quite modest" improvement in outlook or the successful execution of an asset sale could have "a very material impact" on the share price.

Reporting by Iain Gilbert at

Share this article

Related Sharecast Articles

R&Q Insurance shares plummet on weak guidance
(Sharecast News) - R&Q Insurance, the AIM-listed non-life insurer, lost almost half of its market value on Friday after announcing it would report a "significant pre-tax loss" for last year.
SigmaRoc delivers 'solid' Q1 performance
(Sharecast News) - Limestone group SigmaRoc said on Friday that it had delivered a "solid Q1 performance", with underlying earnings in line with management expectations.
Samsung in line to secure $6bn in US government grants
(Sharecast News) - Electronics giant Samsung will unveil a $44.0bn White House programme aimed at bringing semiconductor production back to America as soon as next week, with the memory chip maker in line to secure up to $6.0bn in government grants.
BAE Systems 'still riding high', says Deutsche Bank
(Sharecast News) - Deutsche Bank has hiked its target price for BAE Systems and maintained a 'buy' rating on the aerospace and defence stock, saying that recent growth momentum is likely to continue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.